These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 19243846
1. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Georg P, Kirisits C, Goldner G, Dörr W, Hammer J, Pötzi R, Berger D, Dimopoulos J, Georg D, Pötter R. Radiother Oncol; 2009 May; 91(2):173-80. PubMed ID: 19243846 [Abstract] [Full Text] [Related]
2. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S. Brachytherapy; 2008 May; 7(4):336-42. PubMed ID: 18782683 [Abstract] [Full Text] [Related]
3. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Koom WS, Sohn DK, Kim JY, Kim JW, Shin KH, Yoon SM, Kim DY, Yoon M, Shin D, Park SY, Cho KH. Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1446-54. PubMed ID: 17482766 [Abstract] [Full Text] [Related]
4. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, Weitmann H, Reinthaller A, Knocke TH, Wachter S, Kirisits C. Radiother Oncol; 2007 May 01; 83(2):148-55. PubMed ID: 17531904 [Abstract] [Full Text] [Related]
5. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):901-11. PubMed ID: 15936576 [Abstract] [Full Text] [Related]
6. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy. Georg P, Pötter R, Georg D, Lang S, Dimopoulos JC, Sturdza AE, Berger D, Kirisits C, Dörr W. Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):653-7. PubMed ID: 21345618 [Abstract] [Full Text] [Related]
7. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):756-64. PubMed ID: 18191335 [Abstract] [Full Text] [Related]
8. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. Hyun Kim T, Choi J, Park SY, Lee SH, Lee KC, Yang DS, Shin KH, Cho KH, Lim HS, Kim JY. Cancer; 2005 Sep 15; 104(6):1304-11. PubMed ID: 16078262 [Abstract] [Full Text] [Related]
9. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. Leborgne F, Fowler JF, Leborgne JH, Zubizarreta E, Chappell R. Radiat Oncol Investig; 1997 Sep 15; 5(6):289-99. PubMed ID: 9436246 [Abstract] [Full Text] [Related]
10. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Dimopoulos JC, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, Dörr W, Pötter R. Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):56-63. PubMed ID: 19289267 [Abstract] [Full Text] [Related]
11. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer. Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Yoshida M, Furuya S, Tanaka E, Uegaki T, Kuriyama K, Matsumoto H, Yamada S, Ban C. Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):765-72. PubMed ID: 19836165 [Abstract] [Full Text] [Related]
12. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Dimopoulos JC, Pötter R, Lang S, Fidarova E, Georg P, Dörr W, Kirisits C. Radiother Oncol; 2009 Nov 01; 93(2):311-5. PubMed ID: 19679365 [Abstract] [Full Text] [Related]
13. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer. Wang CJ, Huang EY, Sun LM, Chen HC, Fang FM, Hsu HC, Changchien CC, Leung SW. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):179-89. PubMed ID: 15093915 [Abstract] [Full Text] [Related]
15. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy. Gao M, Albuquerque K, Chi A, Rusu I. Brachytherapy; 2010 May 01; 9(1):55-60. PubMed ID: 19853536 [Abstract] [Full Text] [Related]
18. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma. Muschitz S, Petrow P, Briot E, Petit C, De Crevoisier R, Duvillard P, Morice P, Haie-Meder C. Radiother Oncol; 2004 Nov 01; 73(2):187-94. PubMed ID: 15542166 [Abstract] [Full Text] [Related]
19. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Beriwal S, Bhatnagar A, Heron DE, Selvaraj R, Mogus R, Kim H, Gerszten K, Kelley J, Edwards RP. Brachytherapy; 2006 Nov 01; 5(4):218-22. PubMed ID: 17118313 [Abstract] [Full Text] [Related]
20. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magné N. Radiother Oncol; 2009 Nov 01; 93(2):316-21. PubMed ID: 19586673 [Abstract] [Full Text] [Related] Page: [Next] [New Search]